Earnings Review: AstraZeneca Increases Profit Outlook, Reports 17% EPS Growth
November 09, 2023 at 07:12 AM EST
AstraZeneca reported an EPS of $1.73 for Q3 2023 and $5.8 for 9M 2023.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|